Situation normale

GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline
 SA

1300 Wavre
Since 01/01/1968
BE0403066474
Financial Health Indicator
8
Equity
€25.4M
+19% YoY
Operating Income
€206.5M
+23% YoY
EBITDA
€6.0M
+50% YoY
Gain/Loss
€4.1M
+70% YoY
Employees
200
+4% YoY

GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s business network visualized

Explore our interactive spiderweb to visually navigate GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline
GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline
  • Catherine Elhaut
    1300 Wavre
    Since 2023
  • Anne-Sophie Aernouts
    1300 Wavre
    Since 2023
  • Emmanuelle Reignault
  • Emmanuelle Boishardy
    1300 Wavre
    Since 2023

Detailed insights into GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s financial history

See financial trends including, equity, operating income, profit/loss and employees of GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2023 2022 2021 2020 2019
Equity
25.4M
21.2M
21.8M
18.8M
15.8M
Operating Income
206.5M
167.6M
160.0M
169.6M
186.8M
Gain/Loss
4.1M
2.4M
3.0M
3.0M
3.7M
Employees
200
193
191
187
179

Recent news articles about GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline

Thanks to our exclusive partnership with business and economics newspaper De Tijd and L’Echo, we can provide deep analysis of related news articles with relations between entities.

30/09/2024

Belgische CEO Marianne De Backer saneert fors bij Amerikaans biotechbedrijf

De Tijd
09/02/2022

Boomende Belgische farma vecht om schaars talent

De Tijd
04/11/2021

Novartis en Roche beëindigen jarenlange Mexicaanse stand-off

De Tijd

Frequently asked questions about GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline

  • What is GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s official website?

    GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s official website is https://www.essenscia.be/chemie-en-life-sciences/onze-leden/glaxosmithkline-vaccines-4.
  • Where is GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline located?

    GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s headquarters is located in Avenue Fleming 20 , 1300 Wavre.
  • Who are the directors of GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline?

    GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s directors include
    • Catherine Elhaut
    • Anne-Sophie Aernouts
    • Emmanuelle Reignault
    • Emmanuelle Boishardy
  • When was GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline founded?

    GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline was founded in 1968-01-01. GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline has been active for 57 years.
  • What are GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s NACEBEL codes?

    GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s NACEBEL codes are
    • 46460 Commerce de gros de produits pharmaceutiques et médicaux (2025)
    • 46460 Commerce de gros de produits pharmaceutiques (2008)
    • 51460 Commerce de gros de produits pharmaceutiques (2003)
  • What is GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s VAT number?

    GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s VAT number is BE0403066474.
  • What is GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s juridical form?

    GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s juridical type is Société anonyme (SA).
  • How many employees does GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline have?

    GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline has 200 employees.
  • How is the financial situation of GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline?

    openthebox has estimated that GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline’s financial health score to be 8/10.